HOME >> BIOLOGY >> NEWS
Aspirin use safe and effective in patients with abnormal red cell counts (or with polycythemia)

(San Diego, Calif., December 7, 2003) The use of low-dose aspirin significantly reduces the risk of thrombosis in patients with polycythemia vera, an abnormal increase in blood cells resulting from excess production by the bone marrow, according to a study presented today during the 45th Annual Meeting of the American Society of Hematology. Thrombosis is the formation or presence of a blood clot within a vessel that may cause a stroke or heart attack.

"These results indicate a high benefit/risk ratio of aspirin in a polycythemic population, suggesting that aspirin should be used in all patients with polycythemia vera having no contraindication to this treatment," said Raffaele Landolfi, M.D., of the Istituto di Medicina Interna e Geriatria, Universit Cattolica, Rome, Italy, lead author of the study.

Aspirin treatment (100 mg per day) significantly reduced the risk of thrombosis in polycythemic patients who were undergoing standard cytoreductive treatments (therapies aimed at reducing the number of blood cells). Treatment with aspirin lowered the risk of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, pulmonary embolism, and venous thrombosis. The risk of minor thrombotic events was also significantly decreased.

Researchers reported no excess of major bleeding in patients on aspirin treatment. Major, total, and gastrointestinal bleedings were not significantly increased. Only the risk of nosebleeds, or epistaxix, was significantly increased.

Polycythemia vera is an acquired disorder of the bone marrow that causes the overproduction of all three blood cell lines white and red blood cells and platelets. It is a relatively rare disease that occurs more frequently in men than women, usually within the age range of 40 to 80, although it may occur in younger subjects. Polycythemia vera develops slowly, and most patients do not experience any problems related to the disease
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
7-Dec-2003


Page: 1 2

Related biology news :

1. Aspirin may not be strong enough to prevent clots in some heart patients
2. Aspirin could reduce the risk of deadly infections
3. Aspirin prevents polyps in colon cancer patients
4. Aspirin inhibits ovarian cancer growth, lab study finds
5. Aspirin targets key cell that triggers organ rejection and other immune responses, report University of Pittsburgh researchers in journal article
6. Aspirin use may increase pancreatic cancer risk
7. How Super Are The "Super Aspirins"? -- New COX-2 Inhibitors May Elevate Cardiovascular Risk
8. Aspirin Decreases Genetic Mutations Associated With Inherited Colon Cancer
9. Study Shows Aspirin Blocks "Plant Pain"
10. Aspirins Preventive Action In Heart Attacks Tied To Genetics
11. International study findings link acne-like rash to effectiveness of new targeted cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the ... million people each year. Especially those living in larger cities are affected by air ... one of the most pollution-affected countries globally - decided to take action. , “I ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
Breaking Biology Technology:
Cached News: